e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Exhaled biomarkers in monitoring airways disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Fractional exhaled nitric oxide in chronic obstructive pulmonary disease
Gareth Hynes (Oxford, United Kingdom), Gareth Hynes, Christopher Brightling, Mona Bafadhel
Source:
International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Session:
Exhaled biomarkers in monitoring airways disease
Session type:
Thematic Poster Session
Number:
3993
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Gareth Hynes (Oxford, United Kingdom), Gareth Hynes, Christopher Brightling, Mona Bafadhel. Fractional exhaled nitric oxide in chronic obstructive pulmonary disease. Eur Respir J 2015; 46: Suppl. 59, 3993
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases
Source: International Congress 2015 – IIPs: orphan
Year: 2015
Exhaled nitric oxide levels in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic II
Year: 2016
Role of fractional exhaled nitric oxide(FeNO) in obstructive airway diseases in Indian population
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity
Year: 2016
Fractional exhaled nitric oxide for eosinophilic inflammation in stable COPD
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide
Source: Eur Respir J 2007; 30: 26-30
Year: 2007
Fractional exhaled nitric oxide in pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013
Exhaled nitric oxide and hydrogen peroxide in patients with asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2007; 30: Suppl. 51, 617s
Year: 2007
Exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017
The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD)
Source: Annual Congress 2013 –The vulnerable patient and ageing cells
Year: 2013
Fractional exhaled nitric oxide is associated with more severe asthma
Source: International Congress 2018 – Biomarkers for evaluating asthma
Year: 2018
Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Exhaled nitric oxide in respiratory diseases other than asthma
Source: Eur Respir Monogr 2010; 49: 45-55
Year: 2010
Use of different exhaled nitric oxide multiple flow rate models in COPD
Source: Eur Respir J 2007; 29: 651-659
Year: 2007
Exhaled nitric oxide (NO) in patients with chronic cough
Source: Eur Respir J 2004; 24: Suppl. 48, 580s
Year: 2004
Exhaled nitric oxide increases in chronic eosinophilic pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 509s
Year: 2002
An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis
Source: Eur Respir J 2004; 24 : 609-614
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept